Literature DB >> 16154658

Promoter- and strain-selective enhancement of gene expression in a mouse skeletal muscle by a polymer excipient Pluronic P85.

Zhihui Yang1, Jian Zhu, Srikanth Sriadibhatla, Catherine Gebhart, Valery Alakhov, Alexander Kabanov.   

Abstract

Amphiphilic triblock copolymers of ethylene oxide and propylene oxide (Pluronic) significantly enhanced expression of plasmid DNA in the skeletal muscle. In the presence of Pluronic P85 (P85) high levels of expression of a reporter gene (luciferase) were sustained for at least 40 days and the area under the gene expression curve increased by at least 10 times compared to the DNA alone. The effect of Pluronic depended on the strain of the mouse and the type of the promoter used. Thus, P85 enhanced luciferase expression by 17 to 19-fold in immunocompetent C57Bl/6 and Balb/c mice, while no enhancement was observed with athymic Balb/c nu/nu mice. Furthermore, P85 activated the expression of luciferase gene driven by CMV promoter, NFkappaB and p53 response elements. There was much less or no effect on the gene driven by SV40 promoter or AP1 and CRE response elements. Overall, the promoter selectivity suggested that Pluronic induced transcriptional activation of gene expression by activating the p53 and NFkappaB signaling pathways. In addition Pluronic increased the number of DNA copies and thus affected initial stages of gene transfer in a promoter selective manner.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16154658     DOI: 10.1016/j.jconrel.2005.08.015

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  20 in total

1.  Combined pluronic P85- and ultrasound contrast agents-mediated gene transfection to HepG2 cells.

Authors:  Xijun Zhang; Kaiyan Li; Xian Cui; Liangjun Hu; Yunchao Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-12-16

2.  Horizontal gene transfer from macrophages to ischemic muscles upon delivery of naked DNA with Pluronic block copolymers.

Authors:  Vivek Mahajan; Zagit Gaymalov; Daria Alakhova; Richa Gupta; Irving H Zucker; Alexander V Kabanov
Journal:  Biomaterials       Date:  2015-10-09       Impact factor: 12.479

3.  A Low Protein Binding Cationic Poly(2-oxazoline) as Non-Viral Vector.

Authors:  Zhijian He; Lei Miao; Rainer Jordan; Devika S-Manickam; Robert Luxenhofer; Alexander V Kabanov
Journal:  Macromol Biosci       Date:  2015-04-02       Impact factor: 4.979

4.  Poly(alkylene oxide) copolymers for nucleic acid delivery.

Authors:  Swati Mishra; Lavanya Y Peddada; David I Devore; Charles M Roth
Journal:  Acc Chem Res       Date:  2012-01-19       Impact factor: 22.384

5.  Polyethylenimine-modified pluronics (PCMs) improve morpholino oligomer delivery in cell culture and dystrophic mdx mice.

Authors:  Mingxing Wang; Bo Wu; Peijuan Lu; Caryn Cloer; Jay D Tucker; Qilong Lu
Journal:  Mol Ther       Date:  2012-11-20       Impact factor: 11.454

6.  Synthesis and evaluation of amphiphilic poly(tetrahydrofuran-b-ethylene oxide) copolymers for DNA delivery into skeletal muscle.

Authors:  Catherine Pomel; Christian Leborgne; Hervé Cheradame; Daniel Scherman; Antoine Kichler; Philippe Guegan
Journal:  Pharm Res       Date:  2008-09-03       Impact factor: 4.200

Review 7.  Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers.

Authors:  Elena V Batrakova; Alexander V Kabanov
Journal:  J Control Release       Date:  2008-04-24       Impact factor: 9.776

8.  Efficient expression of vascular endothelial growth factor using minicircle DNA for angiogenic gene therapy.

Authors:  Chien-Wen Chang; Lane V Christensen; Minhyung Lee; Sung Wan Kim
Journal:  J Control Release       Date:  2007-10-24       Impact factor: 9.776

9.  Efficacy and mechanism of poloxamine-assisted polyplex transfection.

Authors:  Jeremy Zhang; Sooneon Bae; Jeoung Soo Lee; Ken Webb
Journal:  J Gene Med       Date:  2013 Aug-Sep       Impact factor: 4.565

10.  Interactions of pluronic block copolymers on P-gp efflux activity: experience with HIV-1 protease inhibitors.

Authors:  Naveed Shaik; Guoyu Pan; William F Elmquist
Journal:  J Pharm Sci       Date:  2008-12       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.